Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3108019 | Clinical Queries: Nephrology | 2013 | 5 Pages |
Abstract
Membranoproliferative glomerulonephritis (MPGN) is a heterogeneous entity depicting a similar pattern of glomerular injury secondary to different aetiologies. It is one of the primary glomerular diseases contributing for development of end stage renal disease. There is no definitive treatment of MPGN owing to the lack of understanding the aetiopathogenesis. Over the last decade, there has been publication of enormous literature regarding its pathogenesis, understanding, clinically compatible reclassification and thus a step forward in treatment.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Critical Care and Intensive Care Medicine
Authors
Manjusha Yadla,